Skip to content
Application 207181
- Type
- ANDA
- Sponsor
- DEVA HOLDING AS
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ESOMEPRAZOLE SODIUM | ESOMEPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | EQ 40MG BASE/VIAL | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 17478-850 | Esomeprazole Sodium | Esomeprazole Sodium | Akorn, Inc. | ANDA | Current |
| 17478-850 | Esomeprazole Sodium | Esomeprazole Sodium | Akorn, Inc. | ANDA | Current |
| 17478-850 | Esomeprazole Sodium | Esomeprazole Sodium | Akorn, Inc. | ANDA | Current |
| 17478-850 | Esomeprazole Sodium | Esomeprazole Sodium | Akorn, Inc. | ANDA | Current |
| 17478-850 | Esomeprazole Sodium | Esomeprazole Sodium | Akorn | ANDA | Current |